0001127602-17-002250.txt : 20170124
0001127602-17-002250.hdr.sgml : 20170124
20170124092516
ACCESSION NUMBER: 0001127602-17-002250
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170120
FILED AS OF DATE: 20170124
DATE AS OF CHANGE: 20170124
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Babu Yarlagadda S
CENTRAL INDEX KEY: 0001452635
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 17542644
MAIL ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-01-20
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001452635
Babu Yarlagadda S
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Senior VP - Drug Discovery
Common Stock
2017-01-20
4
F
0
5083
5.95
D
104706
D
Shares withheld by BioCryst Pharmaceuticals, Inc. to satisfy the reporting person's federal and state tax withholding obligations upon the vesting of restricted stock units granted in 2014.
/s/ Alane P. Barnes, by power of attorney
2017-01-24